GBR-13069

GBR-13069 is a psychostimulant and selective dopamine reuptake inhibitor.[1]

GBR-13069

Names
IUPAC name 1-{2-[Bis(4-fluorophenyl)methoxy]ethyl}-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine
Identifiers
3D model (JSmol)	Interactive image
ChemSpider	4767934
PubChem CID	5974189
InChI InChI=1S/C28H30F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-15,28H,16-22H2/b7-4+ Key: DASHZBBQOARCMQ-QPJJXVBHSA-N InChI=1/C28H30F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-15,28H,16-22H2/b7-4+ Key: DASHZBBQOARCMQ-QPJJXVBHBX
SMILES C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CC=CC=C4
Properties
Chemical formula	C28H30F2N2O
Molar mass	448.558 g·mol^−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

• Vanoxerine
• GBR-12783
• GBR-12935
• GBR-13098
• DBL-583

References

1. "In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion". Eur. J. Pharmacol. 230 (2): 195–201. January 1993. doi:10.1016/0014-2999(93)90802-o. PMID 8422901.